Related Experiment Video
Updated: Oct 4, 2025
09:25
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
19.3K
[Current status of chondrosarcoma in a reference center]
M A Clara-Altamirano1, D Y García-Ortega1, M Núñez-González2
1Departamento de Piel y Partes Blandas Instituto Nacional de Cancerología. Ciudad de México. México.
Acta Ortopedica Mexicana
|February 9, 2022
Summary
Metastases and axial localization are key factors influencing survival in chondrosarcoma patients. This study analyzed demographic and treatment data to understand chondrosarcoma prognosis.
Area of Science:
- Orthopedics
- Oncology
- Pathology
Background:
- Chondrosarcoma is the second most common primary malignant bone tumor.
- Characterized by chondroid matrix formation, it affects older individuals.
- Prognosis depends on histological subtype and tumor grade.
Purpose of the Study:
- To present the demographic and treatment profile of chondrosarcoma patients.
- To identify prognostic factors influencing survival in a reference center.
Main Methods:
- Retrospective, descriptive, observational, analytical cohort study.
- Data collected from January 1, 2005, to December 31, 2019.
- Demographic variables analyzed against overall survival and disease-free period.
Main Results:
- 85 patients included; mean age 43.3 years.
- Clinical stages IIa and IIb were most common (54.1%).
- 35 patients had stage IV metastases (37.6% to lungs); 42.3% experienced specific mortality.
Conclusions:
- Presence of metastases significantly impacts overall survival.
- Axial tumor localization is another critical prognostic factor.
